LLY
Eli Lilly and CompanyNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$808.22B
P/E Ratio
39.68
EPS
$22.76
Beta
0.43
52W High
$1132.06
52W Low
$620.46
50-Day MA
$1018.03
200-Day MA
$893.97
Dividend Yield
0.66%
Profit Margin
31.70%
Forward P/E
26.45
PEG Ratio
0.97
About Eli Lilly and Company
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
Fundamentals
| Revenue (TTM) | $65.18B |
| Gross Profit (TTM) | $54.13B |
| EBITDA | $31.69B |
| Operating Margin | 44.90% |
| Return on Equity | 101.20% |
| Return on Assets | 19.40% |
| Revenue/Share (TTM) | $72.64 |
| Book Value | $29.66 |
| Price-to-Book | 30.39 |
| Price-to-Sales (TTM) | 12.40 |
| EV/Revenue | 12.91 |
| EV/EBITDA | 26.56 |
| Quarterly Earnings Growth (YoY) | 51.40% |
| Quarterly Revenue Growth (YoY) | 42.60% |
| Shares Outstanding | $892.99M |
| Float | $890.98M |
| % Insiders | 0.19% |
| % Institutions | 84.75% |
Historical Volatility
HV 10-Day
32.16%
HV 20-Day
30.09%
HV 30-Day
30.99%
HV 60-Day
40.99%
HV Rank
36.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($1209.34 target)
6
Strong Buy18
Buy6
Hold1
Strong SellData last updated: 3/25/2026